Further to the Company's announcements made on 21 November 2022, 30 June 2023, 29 September 2023, 4 January 2024, 29 March 2024, 28 June 2024, 30 September 2024, 6 January 2025, 7 April 2025, 3 July 2025, 2 October 2025 and 7 January 2026 pertaining to the Memorandum of Understanding ("MOU") made between the Company and Nanjing University of Chinese Medicine, the Board of Directors of the Company wishes to announce that there is no material development on the status of the MOU as announced previously.
This announcement is dated 8 April 2026.